SCPH logo

scPharmaceuticals (SCPH) Company Overview

Profile

Full Name:

scPharmaceuticals Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 17, 2017

Indexes:

Not included

Description:

scPharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for patients with chronic conditions. They specialize in transforming injectable medications into subcutaneous formulations, enhancing patient convenience and adherence. Their goal is to improve treatment outcomes and quality of life for individuals with serious health issues.

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Craig-Hallum
Buy
Aug 19, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Mar 14, 24 HC Wainwright & Co.
Buy
Sep 7, 23 Craig-Hallum
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
Aug 2, 23 HC Wainwright & Co.
Buy
Jul 19, 23 HC Wainwright & Co.
Buy
Jun 8, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for scPharmaceuticals?
  • Does scPharmaceuticals pay dividends?
  • What sector is scPharmaceuticals in?
  • What industry is scPharmaceuticals in?
  • What country is scPharmaceuticals based in?
  • When did scPharmaceuticals go public?
  • Is scPharmaceuticals in the S&P 500?
  • Is scPharmaceuticals in the NASDAQ 100?
  • Is scPharmaceuticals in the Dow Jones?
  • When was scPharmaceuticals's last earnings report?
  • When does scPharmaceuticals report earnings?
  • Should I buy scPharmaceuticals stock now?

What is the ticker symbol for scPharmaceuticals?

The ticker symbol for scPharmaceuticals is NASDAQ:SCPH

Does scPharmaceuticals pay dividends?

No, scPharmaceuticals does not pay dividends

What sector is scPharmaceuticals in?

scPharmaceuticals is in the Healthcare sector

What industry is scPharmaceuticals in?

scPharmaceuticals is in the Biotechnology industry

What country is scPharmaceuticals based in?

scPharmaceuticals is headquartered in United States

When did scPharmaceuticals go public?

scPharmaceuticals's initial public offering (IPO) was on November 17, 2017

Is scPharmaceuticals in the S&P 500?

No, scPharmaceuticals is not included in the S&P 500 index

Is scPharmaceuticals in the NASDAQ 100?

No, scPharmaceuticals is not included in the NASDAQ 100 index

Is scPharmaceuticals in the Dow Jones?

No, scPharmaceuticals is not included in the Dow Jones index

When was scPharmaceuticals's last earnings report?

scPharmaceuticals's most recent earnings report was on Nov 13, 2024

When does scPharmaceuticals report earnings?

The next expected earnings date for scPharmaceuticals is Mar 13, 2025

Should I buy scPharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions